Orphan designation: Alvelestat Treatment of congenital alpha-1 antitrypsin deficiency, 16/01/2025 Positive | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 20 February 2025 - 13:37

Orphan designation: Alvelestat Treatment of congenital alpha-1 antitrypsin deficiency, 16/01/2025 Positive

Link:

https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu-3-24-3018

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters